Pregled bibliografske jedinice broj: 1182926
Decline of Anti-SARS-CoV-2 IgG Antibody Levels 6 Months after Complete BNT162b2 Vaccination in Healthcare Workers to Levels Observed Following the First Vaccine Dose
Decline of Anti-SARS-CoV-2 IgG Antibody Levels 6 Months after Complete BNT162b2 Vaccination in Healthcare Workers to Levels Observed Following the First Vaccine Dose // Vaccines, 10 (2022), 2; 153, 12 doi:10.3390/vaccines10020153 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1182926 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Decline of Anti-SARS-CoV-2 IgG Antibody Levels 6
Months after Complete BNT162b2 Vaccination in
Healthcare Workers to Levels Observed Following
the First Vaccine Dose
Autori
Đaković Rode, Oktavija ; Bodulić, Kristian ; Zember, Sanja ; Cetinić Balent, Nataša ; Novokmet, Anđa ; Čulo, Marija ; Rašić, Željka ; Mikulić, Radojka ; Markotić, Alemka
Izvornik
Vaccines (2076-393X) 10
(2022), 2;
153, 12
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
6 month longitudinal study ; anti-SARS-CoV-2 antibodies ; BNT162b2 vaccine ; healthcare workers ; Croatia
Sažetak
Research on post-vaccination antibody dynamics has become pivotal in estimating COVID-19 vaccine efficacy. We studied anti-SARS-CoV-2 Spike RBD IgG levels in 587 healthcare workers (2038 sera) who completed BNT162b2 vaccination. Average antibody titer 3 weeks after the first dose in COVID-19- naïve participants (median 873.5 AU/mL) was 18- fold higher than the test threshold, with a significant increase 1 month (median 9927.2 AU/mL) and an exponential decrease 3 (median 2976.7 AU/mL) and 6 (median 966.0 AU/mL) months after complete vaccination. Participants with a history of COVID-19 prior to vaccination showed significantly higher antibody levels, particularly after the first dose (median 14, 280.2 AU/mL), with a slight decline 1 month (median 12, 700.0 AU/mL) and an exponential decline in antibody titers 3 (median 4831.0 AU/mL) and 6 (median 1465.2 AU/mL) months after vaccination. Antibody levels of COVID-19-naïve subjects after the first dose were moderately correlated with age (r = −0.4). Multivariate analysis showed a strong independent correlation between IgG levels 6 months after vaccination and both IgG titers after the first dose and 1 month after vaccination (R2 = 0.709). Regardless of pre-vaccination COVID-19 history, IgG levels 6 months after vaccination were comparable to antibody levels reached by COVID-19-naïve participants after the first vaccine dose
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
EK-KK.01.1.1.01.0006 - Jačanje kapaciteta CERVIRVAC-a za istraživanja u virusnoj imunologiji i vakcinologiji (Jonjić, Stipan, EK ) ( CroRIS)
Ustanove:
Stomatološki fakultet, Zagreb,
Medicinski fakultet, Zagreb,
Klinika za infektivne bolesti "Dr Fran Mihaljević",
Hrvatsko katoličko sveučilište, Zagreb
Profili:
Alemka Markotić
(autor)
Oktavija Dakovic Rode
(autor)
Sanja Zember
(autor)
Kristian Bodulić
(autor)
Poveznice na cjeloviti tekst rada:
Pristup cjelovitom tekstu rada doi www.mdpi.com www.ncbi.nlm.nih.govCitiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
Uključenost u ostale bibliografske baze podataka::
- CAB Abstracts
- SciFinder
- China Academic Journals
- DOAJ
- EBSCO
- Gale
- J-Gate
- OpenAIRE
- PATENTSCOPE
- ProQuest